Osaka University Hospital

Suita-shi, Ôsaka 565-0871

1 studies enrolling now · 3 studies all time

What they study most

Biliary Tract Cancer, Immunoglobulin A (IgA) Nephropathy, Immunoglobulin A Nephropathy (IgAN)

Studies at this site

• A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) — Recruiting now
• Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer — Recruiting now
• Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy — Completed